Prediction of bacteremia using TREAT, a computerized decision-support system

被引:59
作者
Paul, M
Andreassen, S
Nielsen, AD
Tacconelli, E
Almanasreh, N
Fraser, A
Yahav, D
Ram, R
Leibovici, L
机构
[1] Rabin Med Ctr, Dept Med E, IL-49100 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Dept Med A, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Aalborg Univ, Ctr Model Based Med Decis Support, Aalborg, Denmark
[5] Univ Cattolica Sacro Cuore, Sch Med, Gemelli Hosp Rome, Dept Infect Dis, Rome, Italy
[6] Univ Freiburg, Freiburg Univ Hosp, Dept Clin Microbiol, Freiburg, Germany
[7] Univ Freiburg, Freiburg Univ Hosp, Hosp Hyg, Freiburg, Germany
关键词
D O I
10.1086/503034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Prediction of bloodstream infection at the time of sepsis onset allows one to make appropriate and economical management decisions. Methods. The TREAT computerized decision-support system uses a causal probabilistic network, which is locally calibrated, to predict cases of bacteremia. We assessed the system's performance in 2 independent cohorts that included patients with suspected sepsis. Both studies were conducted in Israel, Italy, and Germany. Data were collected prospectively and were entered into the TREAT system at the time that blood samples were obtained for culture. Discriminative power was assessed using a receiver-operating characteristics curve. Results. In the first cohort, 790 patients were included. The area under the receiver-operating characteristics curve for prediction of bacteremia using the TREAT system was 0.68 (95% confidence interval [CI], 0.63-0.73). We used TREAT's prediction values to draw thresholds defining a low-,intermediate-, and high- risk groups for bacteremia, in which 3 (2.4%) of 123, 62 (12.8%) of 483, and 55 (29.9%) of 184 patients were bacteremic, respectively. In the second cohort, 1724 patients were included. The area under the receiver-operating characteristics curve was 0.70 ( 95% CI, 0.67-0.73). The prevalence of bacteremia observed in the low-, intermediate-, and high-risk groups defined by the first cohort were 1.3% ( 4 of 300 patients), 13.2% ( 150 of 1139 patients), and 28.1% ( 80 of 285 patients), respectively. The low- risk groups in the 2 cohorts comprised 15%-17% of all patients. Performance was stable in the 3 sites. Conclusions. Using variables available at the time that blood cultures were performed, the TREAT system successfully stratified patients on the basis of the risk for bacteremia. The system's predictions were stable in 3 locations. The TREAT system can define a low- risk group of inpatients with suspected sepsis for whom blood cultures may not be needed.
引用
收藏
页码:1274 / 1282
页数:9
相关论文
共 26 条
[1]  
Andreassen S, 2005, ADV INFO KNOW PROC, P451
[2]   Using probabilistic and decision-theoretic methods in treatment and prognosis modeling [J].
Andreassen, S ;
Riekehr, C ;
Kristensen, B ;
Schonheyder, HC ;
Leibovici, L .
ARTIFICIAL INTELLIGENCE IN MEDICINE, 1999, 15 (02) :121-134
[3]   PREDICTING BACTEREMIA IN HOSPITALIZED-PATIENTS - A PROSPECTIVELY VALIDATED MODEL [J].
BATES, DW ;
COOK, EF ;
GOLDMAN, L ;
LEE, TH .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) :495-500
[4]   Predicting bacteremia in patients with sepsis syndrome [J].
Bates, DW ;
Sands, K ;
Miller, E ;
Lanken, PN ;
Hibberd, PL ;
Graman, PS ;
Schwartz, JS ;
Kahn, K ;
Snydman, DR ;
Parsonnet, J ;
Moore, R ;
Black, E ;
Johnson, BL ;
Jha, A ;
Platt, R .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1538-1551
[5]   CONTAMINANT BLOOD CULTURES AND RESOURCE UTILIZATION - THE TRUE CONSEQUENCES OF FALSE-POSITIVE RESULTS [J].
BATES, DW ;
GOLDMAN, L ;
LEE, TH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (03) :365-369
[6]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[7]   FUTURE IMPERFECT - THE LIMITATIONS OF CLINICAL-PREDICTION MODELS AND THE LIMITS OF CLINICAL-PREDICTION [J].
DIAMOND, GA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (03) :A12-A22
[8]   Building probabilistic networks: "Where do the numbers come from?" - Guest editors' introduction [J].
Druzdzel, MJ ;
van der Gaag, LC .
IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING, 2000, 12 (04) :481-486
[9]   Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis [J].
Fowler, RA ;
Hill-Popper, M ;
Stasinos, J ;
Petrou, C ;
Sanders, GD ;
Garber, AM .
JOURNAL OF CRITICAL CARE, 2003, 18 (03) :181-191
[10]   Effects of computerized clinical decision support systems on practitioner performance and patient outcomes - A systematic review [J].
Garg, AX ;
Adhikari, NKJ ;
McDonald, H ;
Rosas-Arellano, MP ;
Devereaux, PJ ;
Beyene, J ;
Sam, J ;
Haynes, RB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (10) :1223-1238